Picture of Sopharma AD logo

SFA Sopharma AD Cashflow Statement

0.000.00%
bg flag iconLast trade - 00:00
Consumer DefensivesBalancedMid CapNeutral

Annual cashflow statement for Sopharma AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-121-134-148-145-170
Other Operating Cash Flow
Cash from Operating Activities-128-179-7611045
Capital Expenditures-40.4-27-27.1-23.7-43.3
Purchase of Fixed Assets
Other Investing Cash Flow Items-63.828.5-41-40-19.6
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-1041.5-68.1-63.6-62.9
Financing Cash Flow Items20324320430.6-0.513
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities236176157-64.3127
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3.23-2.2212.6-17.9109